Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
The case for direct-to-patient (DTP) has been clearly made. | The case for DTP is made. What separates programs that deliver from ones that stall? Gifthealth breaks down what it actually takes.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

By Andreas Dimakakos Director of Clinical Data, Kate Smietana Director, Knowledge and Thought Leadership, Panos Karelis VP of…

Drug commercialization depends on reaching the right physicians at the right moment. | Drug commercialization depends on reaching…

As pharmaceutical companies expand direct-to-patient (DTP) strategies, many continue to face lengthy implementation timelines…

As therapies become more dependent on testing and diagnosis, we're exploring how biopharma leaders are working to close the gap…

Strengthening core CDO values for cell line development | Strengthening core CDO values for cell line development

How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how…